Cross Country Healthcare (NASDAQ:CCRN) Price Target Cut to $16.50 by Analysts at UBS Group

Cross Country Healthcare (NASDAQ:CCRN) had its price objective decreased by UBS Group from $18.61 to $16.50 in a report issued on Tuesday,Benzinga reports. UBS Group currently has a neutral rating on the business services provider’s stock.

A number of other brokerages also recently issued reports on CCRN. Barrington Research reiterated a “market perform” rating and set a $18.61 price objective on shares of Cross Country Healthcare in a research note on Friday, March 14th. JMP Securities reiterated a “market perform” rating on shares of Cross Country Healthcare in a research note on Thursday, February 6th. Finally, StockNews.com initiated coverage on shares of Cross Country Healthcare in a research note on Wednesday, May 7th. They issued a “hold” rating on the stock. Seven investment analysts have rated the stock with a hold rating, According to MarketBeat.com, Cross Country Healthcare currently has an average rating of “Hold” and a consensus target price of $17.93.

Cross Country Healthcare Stock Performance

NASDAQ:CCRN opened at $13.95 on Tuesday. Cross Country Healthcare has a 52 week low of $9.58 and a 52 week high of $18.50. The firm has a market cap of $457.32 million, a price-to-earnings ratio of -278.94, a P/E/G ratio of 3.32 and a beta of 0.38. The firm’s 50-day simple moving average is $14.55 and its 200 day simple moving average is $15.46.

Cross Country Healthcare (NASDAQ:CCRN) last released its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 0.12% and a positive return on equity of 5.38%. The company’s revenue was down 22.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.19 EPS. Sell-side analysts anticipate that Cross Country Healthcare will post 0.53 EPS for the current year.

Institutional Investors Weigh In On Cross Country Healthcare

Hedge funds have recently added to or reduced their stakes in the business. Barclays PLC boosted its position in Cross Country Healthcare by 117.5% during the 3rd quarter. Barclays PLC now owns 80,277 shares of the business services provider’s stock worth $1,078,000 after buying an additional 43,372 shares during the period. Amundi boosted its position in Cross Country Healthcare by 385.4% during the 4th quarter. Amundi now owns 26,494 shares of the business services provider’s stock worth $483,000 after buying an additional 21,036 shares during the period. Yakira Capital Management Inc. acquired a new stake in Cross Country Healthcare during the 4th quarter worth approximately $1,013,000. Chicago Capital Management LLC acquired a new stake in Cross Country Healthcare during the 4th quarter worth approximately $7,300,000. Finally, Sei Investments Co. boosted its position in Cross Country Healthcare by 7.3% during the 4th quarter. Sei Investments Co. now owns 143,380 shares of the business services provider’s stock worth $2,604,000 after buying an additional 9,816 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.